Sm Dileep Kumar

Title: Sm Dileep Kumar: Innovator in Pharmaceutical Chemistry

Introduction

Sm Dileep Kumar is a notable inventor based in Vizianagaram, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug synthesis. His work has implications for the production of important medications.

Latest Patents

One of his key patents is titled "Process for the preparation of benazepril." This invention relates to an improved method for synthesizing trifluoromethanesulfonic ester of ethyl (R)-2-hydroxy-4-phenylbutyrate, which is referred to as triflate in structural Formula I. The compound serves as an intermediate for the preparation of the ACE (Angiotensin Converting Enzyme) inhibitor, benazepril. Sm Dileep Kumar holds 1 patent in this area.

Career Highlights

Sm Dileep Kumar is currently employed at Ranbaxy Laboratories, Inc., a prominent player in the pharmaceutical industry. His role involves research and development, where he applies his expertise to innovate and improve drug formulations. His contributions have been vital in advancing the company's product offerings.

Collaborations

Throughout his career, Sm Dileep Kumar has collaborated with several talented individuals, including Rajest Kumar Thaper and Yatendra Kumar. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Sm Dileep Kumar's work exemplifies the impact of innovation in pharmaceutical chemistry. His patent for the preparation of benazepril highlights his commitment to improving drug synthesis processes. His contributions continue to influence the pharmaceutical industry positively.